Associated Papers
Case Report: Targeted treatment by fluoxetine/norfluoxetine of a KCNC2 variant causing developmental and epileptic encephalopathy.
Li P et al.
Frontiers in Pharmacology, 2024
Novel KCNC2 variant associated with developmental and epileptic encephalopathy.
Huo L et al.
International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience, 2023
KCNC2 variants of uncertain significance are also associated to various forms of epilepsy.
Seiffert S et al.
Frontiers in Neurology, 2023
Spectrum of Phenotypic, Genetic, and Functional Characteristics in Patients With Epilepsy With KCNC2 Pathogenic Variants.
Schwarz N et al.
Neurology, 2022
Select a paper to view details